How to optimize lipid-lowering therapy for patients with higher CV risk?

Dr Chiu-Lai Fu reviews international guideline recommendations on LDL-C goals and lipid-modifying therapy for patients at high or very high CV risk. Advantages of ezetimibe/statin combination therapy are discussed based on clinical studies and her experience.